Joe Wakil

FGH Biotech, Inc. is a drug discovery and development company that specializes in the development of drugs for the treatment of metabolic disorders. The firm's products are used in various treatment indications, such as obesity, non-alcoholic fatty liver disease, type II diabetes, lipid disorders, cardiovascular disease, and cancer therapy. The company was founded by Salih J. Wakil, Motonari Uesugi and Lutfi Abu-Elheiga in 2011 and is headquartered in Houston, TX.

FGH Biotech, Inc. is a drug discovery and development company that specializes in the development of drugs for the treatment of metabolic disorders. The firm's products are used in various treatment indications, such as obesity, non-alcoholic fatty liver disease, type II diabetes, lipid disorders, cardiovascular disease, and cancer therapy. The company was founded by Salih J. Wakil, Motonari Uesugi and Lutfi Abu-Elheiga in 2011 and is headquartered in Houston, TX.

FGH Biotech, Inc. is a drug discovery and development company that specializes in the development of drugs for the treatment of metabolic disorders. The firm's products are used in various treatment indications, such as obesity, non-alcoholic fatty liver disease, type II diabetes, lipid disorders, cardiovascular disease, and cancer therapy. The company was founded by Salih J. Wakil, Motonari Uesugi and Lutfi Abu-Elheiga in 2011 and is headquartered in Houston, TX.

FGH Biotech, Inc. is a drug discovery and development company that specializes in the development of drugs for the treatment of metabolic disorders. The firm's products are used in various treatment indications, such as obesity, non-alcoholic fatty liver disease, type II diabetes, lipid disorders, cardiovascular disease, and cancer therapy. The company was founded by Salih J. Wakil, Motonari Uesugi and Lutfi Abu-Elheiga in 2011 and is headquartered in Houston, TX.